Literature DB >> 2456628

Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings.

H R Michie1, D R Spriggs, K R Manogue, M L Sherman, A Revhaug, S T O'Dwyer, K Arthur, C A Dinarello, A Cerami, S M Wolff.   

Abstract

After injury, infection, or major operations a number of predictable metabolic responses occur. It has been proposed that the cytokine tumor necrosis factor (TNF)/cachectin is a primary mediator of these host responses. To test this hypothesis, we studied 16 tumor-bearing humans with normal renal and hepatic function, who received 24-hour continuous intravenous infusions of escalating doses of recombinant TNF (4 to 636/micrograms/m2/24 h). Serial measurements were made of vital signs and plasma concentrations of TNF, interleukin-1, adrenocorticotropic hormone, cortisol, iron, glucose, and C-reactive protein. Low doses of TNF had minimal metabolic effects, but infusions of greater than or equal to 545 micrograms/m2/24 hr (n = 8) resulted in fever, pituitary, and stress hormone release and acute phase changes. These alterations were compared with the changes that occurred in healthy humans (n = 13) receiving intravenous bolus injections of Escherichia coli endotoxin (4 ng/kg). TNF infusion in doses greater than or equal to 545 micrograms/m2/24 hr produced peak plasma TNF concentrations and metabolic responses that were similar to those after endotoxin injection. Interleukin-1 concentrations remained basal after TNF or endotoxin administration. TNF may represent the primary afferent signal that initiates many of the metabolic responses associated with sepsis and endotoxemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456628

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  57 in total

1.  The relationship between a nutritional index and acute physiology score in critical illness.

Authors:  D B Gough; M White; M Morrin; W Joyce; D Phelan; J M Fitzpatrick; T F Gorey
Journal:  Ir J Med Sci       Date:  1992-09       Impact factor: 1.568

2.  Sepsis and tumor necrosis factor--bedfellows that cannot be ignored.

Authors:  H R Michie; D W Wilmore
Journal:  Ann Surg       Date:  1990-12       Impact factor: 12.969

3.  Effect of E. coli endotoxin on mammalian cell growth and recombinant protein production.

Authors:  J Epstein; M M Lee; C E Kelly; P K Donahoe
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

Review 4.  The role of mediators in the response to thermal injury.

Authors:  Y K Youn; C LaLonde; R Demling
Journal:  World J Surg       Date:  1992 Jan-Feb       Impact factor: 3.352

5.  Metabolic responses to interleukin-1: centrally and peripherally mediated.

Authors:  A G Hill; J Siegel; J Rounds; D W Wilmore
Journal:  Ann Surg       Date:  1997-03       Impact factor: 12.969

6.  The testicular effects of tumor necrosis factor.

Authors:  K Mealy; B Robinson; C F Millette; J Majzoub; D W Wilmore
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

Review 7.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  Effect of omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation to lactating sows on growth and indicators of stress in the postweaned pig1,2.

Authors:  John M McAfee; Henry G Kattesh; Merlin D Lindemann; Brynn H Voy; Cheryl J Kojima; Nicole C Burdick Sanchez; Jeff A Carroll; Barbara E Gillespie; Arnold M Saxton
Journal:  J Anim Sci       Date:  2019-11-04       Impact factor: 3.159

9.  The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis.

Authors:  Adrian M Piliponsky; Ching-Cheng Chen; Eon J Rios; Piper M Treuting; Asha Lahiri; Magnus Abrink; Gunnar Pejler; Mindy Tsai; Stephen J Galli
Journal:  Am J Pathol       Date:  2012-09       Impact factor: 4.307

10.  Experimental human endotoxemia: a model of the systemic inflammatory response syndrome?

Authors:  Steve E Calvano; Susette M Coyle
Journal:  Surg Infect (Larchmt)       Date:  2012-10-16       Impact factor: 2.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.